C
Cannabis Bioscience International Holdings Inc
OTC:CBIH
Cannabis Bioscience International Holdings Inc
OTC:CBIH
Price:
0.0005
USD
25%
Market Closed
Market Cap:
$5.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cannabis Bioscience International Holdings Inc
OTC:CBIH
|
US |
|
Omega Therapeutics Inc
NASDAQ:OMGA
|
US |
|
C
|
Capital Power Corp
OTC:CPXWF
|
CA |
|
Bengal Energy Ltd
OTC:BNGLF
|
CA |
|
Peak Minerals Ltd
ASX:PUA
|
AU |
|
Green Earth Group NV
AEX:EARTH
|
NL |
|
C
|
Cannlabs Inc
OTC:CANL
|
US |
|
D
|
Daesung Microbiological Labs Co Ltd
KOSDAQ:036480
|
KR |
Balance Sheet
Balance Sheet Decomposition
Cannabis Bioscience International Holdings Inc
Cannabis Bioscience International Holdings Inc
Balance Sheet Decomposition is not available for
Cannabis Bioscience International Holdings Inc
Cannabis Bioscience International Holdings Inc
Balance Sheet
Cannabis Bioscience International Holdings Inc
Cannabis Bioscience International Holdings Inc
Currency: USD
| May-2008 | May-2009 | May-2010 | May-2011 | May-2022 | May-2023 | May-2024 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
10
|
26
|
54
|
31
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
10
|
26
|
53
|
30
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
28
|
56
|
32
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
4
|
6
|
8
|
9
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
4
|
6
|
8
|
9
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
4
|
4
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
1
|
6
|
35
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
17
|
0
|
0
|
0
|
0
|
|
| Total Assets |
18
N/A
|
35
+99%
|
72
+106%
|
93
+30%
|
0
-100%
|
0
-61%
|
0
+32%
|
0
-44%
|
|
| Liabilities | |||||||||
| Accounts Payable |
6
|
11
|
13
|
13
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
2
|
2
|
10
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
7
|
13
|
19
|
27
|
0
|
0
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
8
N/A
|
14
+84%
|
24
+69%
|
31
+31%
|
0
-98%
|
1
+35%
|
1
+79%
|
1
+5%
|
|
| Equity | |||||||||
| Common Stock |
1
|
1
|
42
|
43
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
18
|
4
|
15
|
4
|
5
|
5
|
6
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
3
|
4
|
4
|
5
|
|
| Other Equity |
1
|
2
|
2
|
4
|
0
|
0
|
0
|
0
|
|
| Total Equity |
10
N/A
|
21
+110%
|
48
+130%
|
62
+29%
|
0
N/A
|
1
-64%
|
1
-82%
|
1
-8%
|
|
| Total Liabilities & Equity |
18
N/A
|
35
+99%
|
72
+106%
|
93
+30%
|
0
-100%
|
0
-61%
|
0
+32%
|
0
-44%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
2
|
2
|
13
|
13
|
8 738
|
10 060
|
10 432
|
11 627
|
|
Switch to:
Switch to:
See Also
Discover More
